NYSE:LLY - Eli Lilly And Co Stock Price, News & Analysis

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Tuesday, June 18th. Investors of record on Thursday, August 15th will be given a dividend of $0.645 per share on Tuesday, September 10th. This represents a $2.58 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date of this dividend is Wednesday, August 14th. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) posted its quarterly earnings data on Tuesday, July, 30th. The company reported $1.50 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.45 by $0.05. The company had revenue of $5.64 billion for the quarter, compared to analyst estimates of $5.59 billion. Eli Lilly And Co had a return on equity of 70.86% and a net margin of 33.76%. The business's revenue for the quarter was up .9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.48 EPS. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Wednesday, October 23rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Eli Lilly And Co issued an update on its FY19 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of $5.67-5.77 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.66. The company issued revenue guidance of $22-22.5 billion, compared to the consensus revenue estimate of $22.18 billion.

16 equities research analysts have issued 1 year target prices for Eli Lilly And Co's stock. Their predictions range from $74.51 to $143.00. On average, they expect Eli Lilly And Co's share price to reach $123.1227 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 7 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

News coverage about LLY stock has trended positive recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Eli Lilly And Co earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the next few days. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a decrease in short interest during the month of July. As of July 31st, there was short interest totalling 11,459,200 shares, a decrease of 6.2% from the June 30th total of 12,215,500 shares. Based on an average daily trading volume, of 4,080,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 1.3% of the shares of the stock are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Pfizer (PFE), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Sanofi (SNY), GlaxoSmithKline (GSK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Zoetis (ZTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Intel (INTC), AT&T (T), General Electric (GE), Exxon Mobil (XOM), Gilead Sciences (GILD), Bank of America (BAC) and Verizon Communications (VZ).

Eli Lilly And Co's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.37%), BlackRock Inc. (6.42%), BlackRock Inc. (6.42%), Primecap Management Co. CA (4.47%), Northern Trust Corp (1.15%) and Price T Rowe Associates Inc. MD (0.89%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Daniel Skovronsky, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Jennison Associates LLC, Jennison Associates LLC, Schroder Investment Management Group, Morgan Stanley, Nomura Holdings Inc. and Nomura Holdings Inc.. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Renaissance Technologies LLC, Grantham Mayo Van Otterloo & Co. LLC, AQR Capital Management LLC, BlackRock Inc., BlackRock Inc., Thoroughbred Financial Services LLC and Amundi Pioneer Asset Management Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Daniel Skovronsky, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $109.51.

Eli Lilly And Co has a market capitalization of $105.72 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]